Search

Your search keyword '"Hanai, Nobuhiro"' showing total 576 results
Start Over Author "Hanai, Nobuhiro"
576 results on '"Hanai, Nobuhiro"'

1. Paclitaxel plus cetuximab versus nivolumab for patients with platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis

Author

Kodama, Hiroyuki, Kadowaki, Shigenori, Ishizuka, Yasunobu, Wakabayashi, Munehiro, Sakakida, Tomoki, Honda, Kazunori, Masuishi, Toshiki, Narita, Yukiya, Taniguchi, Hiroya, Ando, Masashi, Kishikawa, Toshihiro, Terada, Hoshino, Beppu, Shintaro, Nishikawa, Daisuke, Suzuki, Hidenori, Hanai, Nobuhiro, and Muro, Kei

Published
2025
Full Text
View/download PDF

3. First-line pembrolizumab with or without chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up of the Japanese population of KEYNOTE‑048

Author

Oridate, Nobuhiko, Takahashi, Shunji, Tanaka, Kaoru, Shimizu, Yasushi, Fujimoto, Yasushi, Matsumoto, Koji, Yokota, Tomoya, Yamazaki, Tomoko, Takahashi, Masanobu, Ueda, Tsutomu, Hanai, Nobuhiro, Yamaguchi, Hironori, Hara, Hiroki, Yoshizaki, Tomokazu, Yasumatsu, Ryuji, Nakayama, Masahiro, Shiga, Kiyoto, Fujii, Takashi, Mitsugi, Kenji, Takahashi, Kenichi, Nohata, Nijiro, Gumuscu, Burak, Lerman, Nati, and Tahara, Makoto

Published
2024
Full Text
View/download PDF

7. Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008

Author

Shimizu, Hidetoshi, Kodaira, Takeshi, Kiyota, Naomi, Hayashi, Ryuichi, Nishino, Hiroshi, Asada, Yukinori, Mitani, Hiroki, Hirayama, Yuuji, Onozawa, Yusuke, Nishio, Naoki, Hanai, Nobuhiro, Ohkoshi, Akira, Hara, Hiroki, Monden, Nobuya, Nagaoka, Masato, Minami, Shujiro, Fujii, Takashi, Tanaka, Kaoru, Homma, Akihiro, Yoshimoto, Seiichi, Oridate, Nobuhiko, Omori, Koichi, Ueda, Tsutomu, Okami, Kenji, Uemura, Hirokazu, Shiga, Kiyoto, Nakahira, Mitsuhiko, Asakage, Takahiro, Saito, Yuki, Sasaki, Keita, Kitabayashi, Ryo, Ishikura, Satoshi, Nishimura, Yasumasa, and Tahara, Makoto

Published
2024
Full Text
View/download PDF

9. Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial

Author

Imamura, Yoshinori, Kiyota, Naomi, Tahara, Makoto, Kodaira, Takeshi, Hayashi, Ryuichi, Nishino, Hiroshi, Asada, Yukinori, Mitani, Hiroki, Iwae, Shigemichi, Nishio, Naoki, Onozawa, Yusuke, Hanai, Nobuhiro, Ohkoshi, Akira, Hara, Hiroki, Monden, Nobuya, Nagaoka, Masato, Minami, Shujiro, Kitabayashi, Ryo, Sasaki, Keita, and Homma, Akihiro

Published
2024
Full Text
View/download PDF

10. Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database

Author

Baliga, Sujith, Abou-Foul, Ahmad K., Parente, Pablo, Szturz, Petr, Thariat, Juliette, Shreenivas, Aditya, Nankivell, Paul, Bertolini, Federica, Biau, Julian, Blakaj, Dukagjin, Brennan, Sinead, Brunet, Aina, De Oliveira, Thiago Bueno, Burtness, Barbara, Maseda, Alberto Carral, Chow, Velda Ling-Yu, Chua, Melvin LK, de Ridder, Mischa, Garikipati, Satya, Hanai, Nobuhiro, Ho, Francis Cho Hao, Huang, Shao Hui, Kiyota, Naomi, Klinghammer, Konrad, Kowalski, Luiz P., Kwong, Dora L, McDowell, Lachlan J, Merlano, Marco Carlo, Nair, Sudhir, Economopoulou, Panagiota, Overgaard, Jens, Psyrri, Amanda, Tribius, Silke, Waldron, John, Yom, Sue S., and Mehanna, Hisham

Published
2024
Full Text
View/download PDF

11. Predictive factors for dissection-free sentinel node micrometastases in early oral squamous cell carcinoma

Author

Matsuzuka, Takashi, Tsukahara, Kiyoaki, Yoshimoto, Seiichi, Chikamatsu, Kazuaki, Shiotani, Akihiro, Oze, Isao, Murakami, Yoshiko, Shinozaki, Takeshi, Enoki, Yuichiro, Ohba, Shinichi, Kawakita, Daisuke, Hanai, Nobuhiro, Koide, Yusuke, Sawabe, Michi, Nakata, Yusuke, Fukuda, Yujiro, Nishikawa, Daisuke, Takano, Gaku, Kimura, Takahiro, Oguri, Keisuke, Hirakawa, Hitoshi, and Hasegawa, Yasuhisa

Published
2023
Full Text
View/download PDF

12. The Landscape of MYB/MYBL1- and Peri-MYB/MYBL1-Associated Rearrangements in Adenoid Cystic Carcinoma

Author

Ueda, Kaori, Murase, Takayuki, Kawakita, Daisuke, Nagao, Toshitaka, Kusafuka, Kimihide, Nakaguro, Masato, Urano, Makoto, Yamamoto, Hidetaka, Taguchi, Ken-ichi, Kano, Satoshi, Tada, Yuichiro, Tsukahara, Kiyoaki, Okami, Kenji, Onitsuka, Tetsuro, Fujimoto, Yasushi, Sakurai, Kazuo, Hanai, Nobuhiro, Nagao, Toru, Kawata, Ryo, Hato, Naohito, Nibu, Ken-ichi, and Inagaki, Hiroshi

Published
2023
Full Text
View/download PDF

14. First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048

Author

Takahashi, Shunji, Oridate, Nobuhiko, Tanaka, Kaoru, Shimizu, Yasushi, Fujimoto, Yasushi, Matsumoto, Koji, Yokota, Tomoya, Yamazaki, Tomoko, Takahashi, Masanobu, Ueda, Tsutomu, Hanai, Nobuhiro, Yamaguchi, Hironori, Hara, Hiroki, Yoshizaki, Tomokazu, Yasumatsu, Ryuji, Nakayama, Masahiro, Shiga, Kiyoto, Fujii, Takashi, Mitsugi, Kenji, Takahashi, Kenichi, Nohata, Nijiro, Gumuscu, Burak, Swaby, Ramona F., and Tahara, Makato

Published
2022
Full Text
View/download PDF

15. Indications for chemoradiotherapy in older patients with locally advanced head and neck cancer in Japan: a questionnaire survey in the JCOG head and neck cancer study group.

Author

Yasuda, Koichi, Kiyota, Naomi, Matsuura, Kazuto, Saito, Satoshi, Honma, Yoshitaka, Imamura, Yoshinori, Tanaka, Kaoru, Zenda, Sadamoto, Onoe, Takuma, Kodaira, Takeshi, Kobayashi, Satoshi, Aoyama, Hidefumi, Hanai, Nobuhiro, and Homma, Akihiro

Subjects
HEAD & neck cancer, OLDER patients, OLDER people, KIDNEY physiology, CANCER patients
Abstract

Introduction: Chemoradiation therapy (CRT) with concurrent high-dose cisplatin (CDDP) is one of the standard treatment options for locally advanced head and neck cancer. Since the indications specific to the older population have not been reported, we conducted a multicenter survey on the indications. Methods: In April and May 2023, a questionnaire survey was emailed to all institutions belonging to the JCOG-HNCSG, consisting of 37 institutions. Results: The major factors influencing the indications for high-dose CDDP were renal function and performance status (PS). The majority agreed that the treatment is administered to patients aged 65–74 years with PS 0–1 and 65–74 years with eGFR ≥60 (ml/ min/1.73m2), and not in patients aged ≥75 years with PS 2, ≥80 years with PS 1, and ≥65 years with eGFR <60. Regarding weekly CDDP, the majority agreed that the treatment is not conducted in patients aged ≥75 years with PS 2, ≥65 years with eGFR <40, and ≥70 years with eGFR <50. Discussion: In Japan, where CRT is actively performed even among older people, a survey was conducted to determine its indications. Renal function and PS were considered important, and comorbidities, such as heart failure, were considered while determining the indication. These results will help define the eligibility criteria for prospective studies on CRT in older patients. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

16. Segmental mandibular resection and reconstruction using a multidisciplinary approach in adolescent and young adult patients: A case of Ewing sarcoma with a eight-year follow-up.

Author

Hagiwara, Sumitaka, Hyodo, Ikuo, Nishikawa, Daisuke, Ando, Masashi, Maeda, Naoko, Ozawa, Shogo, Hasegawa, Yasuhisa, and Hanai, Nobuhiro

Abstract

Ewing sarcoma (ES) is a rare malignant tumor, particularly in the head and neck region. Its incidence tends to be higher in pediatric patients than in adults. Occasionally, curative treatment of ES requires extensive resection of the primary lesion, which can result in postoperative aesthetic or functional disorders. In recent years, advances have been made in reconstructive surgery of the maxillofacial region. Broad mandibular defects are a prime indication for several types of vascularized free bone grafts. Similarly, the treatment of ES has progressed in the field of systemic chemotherapy. We report a multidisciplinary surgical case of ES in the mandible of a 12-year-old patient who underwent extensive mandibular resection and fibula free flap (FFF) reconstruction with preoperative and postoperative chemotherapy. In brief, after conducting a multidisciplinary clinical conference, perioperative chemotherapy was planned by pediatric oncologists, and the operation was performed by a head and neck cancer team consisting of head and neck, oral and maxillofacial, and plastic surgeons. Five months after the operation, prosthodontists applied an intraoral prosthesis. The reconstructed mandible demonstrated good development, and the quality of life was maintained both aesthetically and functionally for eight years after treatment. Our efficient multidisciplinary medical collaboration demonstrated that mandibular reconstruction using FFF is a suitable method for treating pediatric patients and leads to long-term survival with satisfactory outcomes. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

17. Lymph node density as prognostic factor in regional recurrent or residual head and neck cancer.

Author

Goto, Seiya, Suzuki, Hidenori, Beppu, Shintaro, Nishikawa, Daisuke, Sawabe, Michi, Terada, Hoshino, Hanai, Nobuhiro, and Sone, Michihiko

Abstract

Copyright of Acta Oto-Laryngologica is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2025
Full Text
View/download PDF

18. Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study

Author

Yasumatsu, Ryuji, Shimizu, Yasushi, Hanai, Nobuhiro, Kariya, Shin, Yokota, Tomoya, Fujii, Takashi, Tsukahara, Kiyoaki, Ando, Mizuo, Hanyu, Kenji, Ueda, Tsutomu, Hirakawa, Hitoshi, Takahashi, Shunji, Ono, Takeharu, Sano, Daisuke, Yamauchi, Moriyasu, Watanabe, Akihito, Omori, Koichi, Yamazaki, Tomoko, Monden, Nobuya, Kudo, Naomi, Arai, Makoto, Yonekura, Syuji, Asakage, Takahiro, Nekado, Takahiro, Yamada, Takayuki, and Homma, Akihiro

Published
2022
Full Text
View/download PDF

22. Effectiveness of nivolumab affected by prior cetuximab use and neck dissection in Japanese patients with recurrent or metastatic head and neck cancer: results from a retrospective observational study in a real-world setting

Author

Kariya, Shin, Shimizu, Yasushi, Hanai, Nobuhiro, Yasumatsu, Ryuji, Yokota, Tomoya, Fujii, Takashi, Tsukahara, Kiyoaki, Yoshida, Masafumi, Hanyu, Kenji, Ueda, Tsutomu, Hirakawa, Hitoshi, Takahashi, Shunji, Ono, Takeharu, Sano, Daisuke, Yamauchi, Moriyasu, Watanabe, Akihito, Omori, Koichi, Yamazaki, Tomoko, Monden, Nobuya, Kudo, Naomi, Arai, Makoto, Yonekura, Shuji, Asakage, Takahiro, Fujiwara, Akinori, Yamada, Takayuki, and Homma, Akihiro

Published
2021
Full Text
View/download PDF

23. Frequency of use and cost in Japan of first-line palliative chemotherapies for recurrent or metastatic squamous cell carcinoma of the head and neck.

Author

Yokoyama, Kazuki, Wasano, Koichiro, Sasaki, Keita, Machida, Ryunosuke, Nakahira, Mitsuhiko, Kitamura, Koji, Sakagami, Tomofumi, Takeshita, Naohiro, Ohkoshi, Akira, Suzuki, Motoyuki, Tateya, Ichiro, Morishita, Yohei, Sekimizu, Mariko, Nakayama, Masahiro, Koyama, Taiji, Shibata, Hirofumi, Miyamaru, Satoru, Kiyota, Naomi, Hanai, Nobuhiro, and Homma, Akihiro

Published
2024
Full Text
View/download PDF

24. Effect of acute kidney injury and overall survival in patients with postoperative head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of the phase II/III trial of JCOG1008.

Author

Imamura, Yoshinori, Kiyota, Naomi, Tahara, Makoto, Kodaira, Takeshi, Hayashi, Ryuichi, Nishino, Hiroshi, Asada, Yukinori, Mitani, Hiroki, Iwae, Shigemichi, Nishio, Naoki, Onozawa, Yusuke, Hanai, Nobuhiro, Ohkoshi, Akira, Hara, Hiroki, Monden, Nobuya, Nagaoka, Masato, Minami, Shujiro, Kitabayashi, Ryo, Sasaki, Keita, and Homma, Akihiro

Subjects
HEAD & neck cancer, ACUTE kidney failure, OVERALL survival, CISPLATIN, CONFIDENCE intervals, CHEMORADIOTHERAPY
Abstract

Background: In a randomized phase II/III trial (JCOG1008), weekly cisplatin (40 mg/m2) was non‐inferior to 3‐weekly cisplatin (100 mg/m2) for postoperative high‐risk head and neck cancer. We investigated how acute kidney injury (AKI), a major dose‐limiting toxicity effect of cisplatin, affects overall survival (OS). Methods: We analyzed 251 patients from JCOG1008 receiving chemoradiotherapy. AKI was defined based on AKI Network criteria (serum creatinine increase of ≥0.3 mg/dL or ≥1.5‐fold [≥ stage I]) within 30 days after completing chemoradiotherapy. OS in the two arms was compared according to AKI development using the log‐rank test. Results: The total incidence of AKI was lower in the weekly arm than in the 3‐weekly arm (38/122 [31.1%] vs. 56/129 [43.4%]). Additionally, stage II/III AKI occurred less frequently in the weekly arm than in the 3‐weekly arm (8/122 [6.6%] vs. 19/129 [14.7%]). Cisplatin doses were similar in the weekly arm for patients with and without AKI (median, 238.6 mg/m2 vs. 239.2 mg/m2; p = 0.94), but lower in the 3‐weekly arm for those who developed AKI (median, 276.3 mg/m2 vs. 297.4 mg/m2; p = 0.007). In the weekly arm, there was no difference in OS between patients with and without AKI (hazard ratio [HR], 1.06; 95% confidence interval [CI], 0.53 to 2.10). However, in the 3‐weekly arm, patients with AKI had poorer OS than those without AKI (HR, 1.83; 95% CI, 1.04 to 3.21). Conclusions: In this supplementary analysis of JCOG1008 data, AKI impacted the OS of patients with head and neck cancer undergoing postoperative chemoradiotherapy in the 3‐weekly arm but not in the weekly arm. Our results further endorse the utilization of weekly cisplatin at 40 mg/m2 in this setting. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

26. Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study

Author

Hanai, Nobuhiro, Shimizu, Yasushi, Kariya, Shin, Yasumatsu, Ryuji, Yokota, Tomoya, Fujii, Takashi, Tsukahara, Kiyoaki, Yoshida, Masafumi, Hanyu, Kenji, Ueda, Tsutomu, Hirakawa, Hitoshi, Takahashi, Shunji, Ono, Takeharu, Sano, Daisuke, Yamauchi, Moriyasu, Watanabe, Akihito, Omori, Koichi, Yamazaki, Tomoko, Monden, Nobuya, Kudo, Naomi, Arai, Makoto, Sakurai, Daiju, Asakage, Takahiro, Doi, Issei, Yamada, Takayuki, and Homma, Akihiro

Published
2021
Full Text
View/download PDF

28. Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database

Author

MS Radiotherapie, Cancer, Baliga, Sujith, Abou-Foul, Ahmad K., Parente, Pablo, Szturz, Petr, Thariat, Juliette, Shreenivas, Aditya, Nankivell, Paul, Bertolini, Federica, Biau, Julian, Blakaj, Dukagjin, Brennan, Sinead, Brunet, Aina, De Oliveira, Thiago Bueno, Burtness, Barbara, Maseda, Alberto Carral, Chow, Velda Ling Yu, Chua, Melvin LK, de Ridder, Mischa, Garikipati, Satya, Hanai, Nobuhiro, Ho, Francis Cho Hao, Huang, Shao Hui, Kiyota, Naomi, Klinghammer, Konrad, Kowalski, Luiz P., Kwong, Dora L., McDowell, Lachlan J., Merlano, Marco Carlo, Nair, Sudhir, Economopoulou, Panagiota, Overgaard, Jens, Psyrri, Amanda, Tribius, Silke, Waldron, John, Yom, Sue S., Mehanna, Hisham, MS Radiotherapie, Cancer, Baliga, Sujith, Abou-Foul, Ahmad K., Parente, Pablo, Szturz, Petr, Thariat, Juliette, Shreenivas, Aditya, Nankivell, Paul, Bertolini, Federica, Biau, Julian, Blakaj, Dukagjin, Brennan, Sinead, Brunet, Aina, De Oliveira, Thiago Bueno, Burtness, Barbara, Maseda, Alberto Carral, Chow, Velda Ling Yu, Chua, Melvin LK, de Ridder, Mischa, Garikipati, Satya, Hanai, Nobuhiro, Ho, Francis Cho Hao, Huang, Shao Hui, Kiyota, Naomi, Klinghammer, Konrad, Kowalski, Luiz P., Kwong, Dora L., McDowell, Lachlan J., Merlano, Marco Carlo, Nair, Sudhir, Economopoulou, Panagiota, Overgaard, Jens, Psyrri, Amanda, Tribius, Silke, Waldron, John, Yom, Sue S., and Mehanna, Hisham

Published
2024

29. The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan

Author

Kawakita, Daisuke, Murase, Takayuki, Ueda, Kaori, Kano, Satoshi, Tada, Yuichiro, Tsukahara, Kiyoaki, Okami, Kenji, Onitsuka, Tetsuro, Fujimoto, Yasushi, Matoba, Takuma, Sakurai, Kazuo, Nagao, Toru, Hanai, Nobuhiro, Kawata, Ryo, Hato, Naohito, Nibu, Ken-ichi, Urano, Makoto, Taguchi, Ken-ichi, Nakaguro, Masato, Kusafuka, Kimihide, Yamamoto, Hidetaka, Nagao, Toshitaka, and Inagaki, Hiroshi

Published
2020
Full Text
View/download PDF

33. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Author

Lerzo, Guillermo, Tatangelo, Marcelo, Varela, Mirta, Zarba, Juan Jose, Boyer, Michael, Gan, Hui, Gao, Bo, Hughes, Brett, Mallesara, Girish, Rischin, Danny, Taylor, Anne, Burian, Martin, Fuereder, Thorsten, Greil, Richard, Barrios, Carlos Henrique, de Castro Junior, Dalvaro Oliveira, Castro, Gilberto, Franke, Fabio Andre, Girotto, Gustavo, Lima, Iane Pinto Figueiredo, Nicolau, Ulisses Ribaldo, Pinto, Gustavo Dix Junqueira, Santos, Lucas, Victorino, Ana-Paula, Chua, Neil, Couture, Felix, Gregg, Richard, Hansen, Aaron, Hilton, John, McCarthy, Joy, Soulieres, Denis, Ascui, Rodrigo, Gonzalez, Pablo, Villanueva, Luis, Torregroza, Marco, Zambrano, Angela, Holeckova, Petra, Kral, Zdenek, Melichar, Bohuslav, Prausova, Jana, Vosmik, Milan, Andersen, Maria, Gyldenkerne, Niels, Jurgens, Hannes, Putnik, Kadri, Reinikainen, Petri, Gruenwald, Viktor, Laban, Simon, Aravantinos, Gerasimos, Boukovinas, Ioannis, Georgoulias, Vassilis, Psyrri, Amanda, Kwong, Dora, Al-Farhat, Yousuf, Csoszi, Tibor, Erfan, Jozsef, Horvai, Geza, Landherr, Laszlo, Remenar, Eva, Ruzsa, Agnes, Szota, Judit, Billan, Salem, Gluck, Iris, Gutfeld, Orit, Popovtzer, Aron, Benasso, Marco, Bui, Simona, Ferrari, Vittorio, Licitra, Lisa, Nole, Franco, Fujii, Takashi, Fujimoto, Yasushi, Hanai, Nobuhiro, Hara, Hiroki, Matsumoto, Koji, Mitsugi, Kenji, Monden, Nobuya, Nakayama, Masahiro, Okami, Kenji, Oridate, Nobuhiko, Shiga, Kiyoto, Shimizu, Yasushi, Sugasawa, Masashi, Tahara, Makoto, Takahashi, Masanobu, Takahashi, Shunji, Tanaka, Kaoru, Ueda, Tsutomu, Yamaguchi, Hironori, Yamazaki, Tomoko, Yasumatsu, Ryuji, Yokota, Tomoya, Yoshizaki, Tomokazu, Kudaba, Iveta, Stara, Zinaida, Wan Ishak, Wan Zamaniah, Cheah, Soon Keat, Aguilar Ponce, Jose, Gonzalez Mendoza, Rene, Hernandez Hernandez, Carlos, Medina Soto, Francisco, Buter, Jan, Hoeben, Ann, Oosting, S., Suijkerbuijk, Karijn, Bratland, Aase, Brydoey, Marianne, Alvarez, Renzo, Mas, Luis, Caguioa, Priscilla, Querol, John, Regala, Eugenio Emmanuel, Tamayo, Maria Belen, Villegas, Ellie May, Kawecki, Andrzej, Karpenko, Andrey, Klochikhin, Arkadiy, Smolin, Alexey, Zarubenkov, Oleg, Goh, Boon Cher, Cohen, Graham, du Toit, Johanna, Jordaan, Christa, Landers, Gregory, Ruff, Paul, Szpak, Waldemar, Tabane, Neonyana, Brana, Irene, Iglesias Docampo, Lara, Lavernia, Javier, Mesia, Ricard, Abel, Edvard, Muratidu, Valentina, Nielsen, Niels, Cristina, Valerie, Rordorf, Tamara, Rothschild, Sacha, Hong, Ruey-Long, Wang, Hung-Ming, Yang, Muh-Hwa, Yeh, Su-Peng, Yen, Chia-Jui, Ngamphaiboon, Nuttapong, Soparattanapaisarn, Nopadol, Sriuranpong, Virote, Aksoy, Sercan, Cicin, Irfan, Ekenel, Meltem, Harputluoglu, Hakan, Ozyilkan, Ozgur, Harrington, Kevin, Agarwala, Sanjiv, Ali, Haythem, Alter, Robert, Anderson, Daniel, Bruce, Justine, Burtness, Barbara, Campbell, Nicholas, Conde, Miguel, Deeken, John, Edenfield, William, Feldman, Lawrence, Gaughan, Elizabeth, Goueli, Basem, Halmos, Balazs, Hegde, Upendra, Hunis, Brian, Jotte, Robert, Karnad, Anand, Khan, Saad, Laudi, Noel, Laux, Douglas, Martincic, Danko, McCune, Steven, McGaughey, Dean, Misiukiewicz, Krzysztof, Mulford, Deborah, Nadler, Eric, Neupane, Prakash, Nunnink, Johannes, Ohr, James, O'Malley, Meaghan, Patson, Brian, Paul, Doru, Popa, Elizabeta, Powell, Steven, Redman, Rebecca, Rella, Vincent, Rocha Lima, Chaio, Sivapiragasam, Abirami, Su, Yungpo, Sukari, Ammar, Wong, Stuart, Yilmaz, Emrullah, Yorio, Jeffrey, Harrington, Kevin J, Soulières, Denis, de Castro, Gilberto, Jr, Basté, Neus, Bratland, Åse, Hughes, Brett G M, Mesía, Ricard, González Mendoza, René, Roy, Ananya, Zhang, Yayan, Gumuscu, Burak, Cheng, Jonathan D, and Jin, Fan

Published
2019
Full Text
View/download PDF

34. Safety and Efficacy of Gemcitabine Plus Cisplatin Against Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective Study

Author

KODAMA, HIROYUKI, primary, KADOWAKI, SHIGENORI, additional, NAKAZAWA, TAIKO, additional, MATSUBARA, YUKI, additional, NARITA, YUKIYA, additional, HONDA, KAZUNORI, additional, MASUISHI, TOSHIKI, additional, TANIGUCHI, HIROYA, additional, ANDO, MASASHI, additional, KOIDE, YUTARO, additional, TACHIBANA, HIROYUKI, additional, KODAIRA, TAKESHI, additional, SAWABE, MICHI, additional, TERADA, HOSHINO, additional, BEPPU, SHINTARO, additional, NISHIKAWA, DAISUKE, additional, SUZUKI, HIDENORI, additional, HANAI, NOBUHIRO, additional, and MURO, KEI, additional

Published
2024
Full Text
View/download PDF

41. Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma

Author

Iwaki, Sho, primary, Kadowaki, Shigenori, additional, Honda, Kazunori, additional, Narita, Yukiya, additional, Masuishi, Toshiki, additional, Taniguchi, Hiroya, additional, Ando, Masashi, additional, Muro, Kei, additional, Sawabe, Michi, additional, Suzuki, Hidenori, additional, Nishikawa, Daisuke, additional, Beppu, Shintaro, additional, Terada, Hoshino, additional, Kishikawa, Toshihiro, additional, Kawakita, Daisuke, additional, and Hanai, Nobuhiro, additional

Published
2023
Full Text
View/download PDF

43. Extent of thyroidectomy and paratracheal lymph node dissection in total pharyngolaryngectomy for pyriform sinus cancer, and recurrence, survival, and postoperative hypoparathyroidism: A multicenter retrospective study

Author

Ariizumi, Yosuke, primary, Hanai, Nobuhiro, additional, Asakage, Takahiro, additional, Seto, Akira, additional, Tomioka, Toshifumi, additional, Miyabe, Junji, additional, Kessoku, Hisashi, additional, Mukaigawa, Takashi, additional, Omura, Go, additional, Teshima, Masanori, additional, Nishikawa, Daisuke, additional, Saito, Yuki, additional, Asada, Yukinori, additional, Fujisawa, Takuo, additional, Makino, Takuma, additional, Nishino, Hiroshi, additional, Sano, Daisuke, additional, Nakahira, Mitsuhiko, additional, Tokashiki, Kunihiko, additional, Uemura, Hirokazu, additional, Ueda, Tsutomu, additional, Sakai, Akihiro, additional, Masuda, Muneyuki, additional, Tsujikawa, Takahiro, additional, Hiei, Yusuke, additional, Nishio, Naoki, additional, Matsui, Hidetoshi, additional, Kiyota, Naomi, additional, and Homma, Akihiro, additional

Published
2023
Full Text
View/download PDF

44. O9-1 Paclitaxel plus cetuximab vs. nivolumab for patients with platinum-refractory recurrent/metastatic head and neck cancer

Author

Kodama, Hiroyuki, primary, Kadowaki, Shigenori, additional, Wakabayashi, Munehiro, additional, Nakata, Akinobu, additional, Kumanishi, Ryosuke, additional, Nakazawa, Taeko, additional, Ogata, Takatsugu, additional, Matsubara, Yuki, additional, Honda, Kazunori, additional, Masuishi, Toshiki, additional, Narita, Yukiya, additional, Tanigichi, Hiroya, additional, Ando, Masashi, additional, Hanai, Nobuhiro, additional, and Muro, Kei, additional

Published
2023
Full Text
View/download PDF

46. Prognostic scores for patients with salivary adenoid cystic carcinoma without lymph node metastasis

Author

Shimoda, Hikari, primary, Teshima, Masanori, additional, Murase, Takayuki, additional, Nagao, Toshitaka, additional, Kusafuka, Kimihide, additional, Nakaguro, Masato, additional, Urano, Makoto, additional, Taguchi, Ken-ichi, additional, Yamamoto, Hidetaka, additional, Kano, Satoshi, additional, Tada, Yuichiro, additional, Tsukahara, Kiyoaki, additional, Okami, Kenji, additional, Onitsuka, Tetsuro, additional, Fujimoto, Yasushi, additional, Kawakita, Daisuke, additional, Sakurai, Kazuo, additional, Hanai, Nobuhiro, additional, Nagao, Toru, additional, Kawata, Ryo, additional, Hato, Naohito, additional, Nibu, Ken-ichi, additional, and Inagaki, Hiroshi, additional

Published
2023
Full Text
View/download PDF

49. 18: Secondary analysis of JCOG1008: Frequency and risk factors associated with the hypothyroidism

Author

Shimizu, Hidetoshi, Kodaira, Takeshi, Kiyota, Naomi, Hayashi, Ryuichi, Nishino, Hiroshi, Asada, Yukinori, Mitani, Hiroki, Hirayama, Yuuji, Onozawa, Yusuke, Nishio, Naoki, Hanai, Nobuhiro, Ohkoshi, Akira, Hara, Hiroki, Monden, Nobuya, Nagaoka, Masato, Minami, Shujiro, Fujii, Takashi, Tanaka, Kaoru, Homma, Akihiro, Sasaki, Keita, Kitabayashi, Ryo, Ishikura, Satoshi, Nishimura, Yasumasa, and Tahara, Makoto

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results